Literature DB >> 27900406

What does the crystallography of stones tell us about their formation?

Peter Rez1.   

Abstract

The mineral phase makes up most of the mass of a kidney stone. Minerals all come in the form of crystals that are regular arrangements of atoms or molecular groupings at the atomic scale, bounded macroscopically by well-defined crystal faces. Pathologic nephroliths are a polycrystalline aggregate of submicron crystals. Organic macromolecules clearly have an important role in either promoting or preventing aggregation and in altering the morphology of individual submicron crystals by influencing the surface energies of different faces. Crystals, similar in morphology to those grown in solution, are often found for calcium oxalate dihydrate, brushite, cystine and struvite. This is not the case for calcium oxalate monohydrate and hydroxyapatite, two of the most common constituents of stones.

Entities:  

Keywords:  AFM; Crystal structure; SEM; Urolithiasis

Mesh:

Year:  2016        PMID: 27900406     DOI: 10.1007/s00240-016-0951-0

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  61 in total

1.  Serial crystalluria determination and the risk of recurrence in calcium stone formers.

Authors:  Michel Daudon; Carole Hennequin; Ghazi Boujelben; Bernard Lacour; Paul Jungers
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

2.  Crystalluria in marathon runners. III. Stone-forming subjects.

Authors:  A L Rodgers; K G Greyling; T D Noakes
Journal:  Urol Res       Date:  1991

3.  Stable amorphous calcium oxalate: synthesis and potential intermediate in biomineralization.

Authors:  Myriam Hajir; Robert Graf; Wolfgang Tremel
Journal:  Chem Commun (Camb)       Date:  2014-05-13       Impact factor: 6.222

4.  Texture examinations on grain and thin section preparations of calcium oxalate calculi and their relations to pathogenetic parameters.

Authors:  G Schubert; G Brien; S Lenk; R Koch
Journal:  Urol Res       Date:  1983

5.  Calcium oxalate nephrolithiasis, a free or fixed particle disease.

Authors:  D J Kok; S R Khan
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

6.  Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate.

Authors:  S R Khan
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

7.  Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.

Authors:  A M Stapleton; R L Ryall
Journal:  Br J Urol       Date:  1995-06

8.  Transformation mechanism of amorphous calcium carbonate into calcite in the sea urchin larval spicule.

Authors:  Yael Politi; Rebecca A Metzler; Mike Abrecht; Benjamin Gilbert; Fred H Wilt; Irit Sagi; Lia Addadi; Steve Weiner; P U P A Gilbert; Pupa Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

9.  Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.

Authors:  David E Fleming; Arie Van Riessen; Magali C Chauvet; Phulwinder K Grover; Brett Hunter; Wilhelm van Bronswijk; Rosemary L Ryall
Journal:  J Bone Miner Res       Date:  2003-07       Impact factor: 6.741

10.  Mechanism of formation of human calcium oxalate renal stones on Randall's plaque.

Authors:  Andrew P Evan; Fredric L Coe; James E Lingeman; Youzhi Shao; Andre J Sommer; Sharon B Bledsoe; Jennifer C Anderson; Elaine M Worcester
Journal:  Anat Rec (Hoboken)       Date:  2007-10       Impact factor: 2.064

View more
  2 in total

1.  Do organic substances act as a degradable binding matrix in calcium oxalate kidney stones?

Authors:  Adi Adelman; Yaniv Shilo; Jonathan Modai; Dan Leibovici; Ishai Dror; Brian Berkowitz
Journal:  BMC Urol       Date:  2021-03-26       Impact factor: 2.264

2.  Taro raphide-associated proteins: Allergens and crystal growth.

Authors:  Robert E Paull; Dessireé Zerpa-Catanho; Nancy J Chen; Gail Uruu; Ching Man Jennifer Wai; Michael Kantar
Journal:  Plant Direct       Date:  2022-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.